These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8458046)

  • 41. The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy.
    Rodger MA; Gagné-Rodger C; Howley HE; Carrier M; Coyle D; Wells PS
    Thromb Res; 2003; 112(1-2):13-8. PubMed ID: 15013267
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Acute bone and joint infections in children: how much attention should be paid to persistent fever during intravenous antibiotic therapy?].
    Ceroni D; Regusci M; Pazos J; Dayer R; Kaelin A
    Rev Chir Orthop Reparatrice Appar Mot; 2003 May; 89(3):250-6. PubMed ID: 12844049
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost of home and hospital care for patients with cystic fibrosis followed up in two reference medical centers in France.
    Horvais V; Touzet S; François S; Bourdy S; Bellon G; Colin C; Durieu I
    Int J Technol Assess Health Care; 2006; 22(4):525-31. PubMed ID: 16984688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of early versus late conversion from intravenous to oral therapy in the treatment of septic arthritis.
    Ballock RT; Newton PO; Evans SJ; Estabrook M; Farnsworth CL; Bradley JS
    J Pediatr Orthop; 2009 Sep; 29(6):636-42. PubMed ID: 19700997
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cefotaxime and ceftriaxone use evaluation in pediatrics. Considerations of cost effectiveness.
    Lee CK; Glenn DJ
    Diagn Microbiol Infect Dis; 1995; 22(1-2):231-3. PubMed ID: 7587045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of formulary restriction of cefotaxime usage.
    DeVito JM; John JF
    Arch Intern Med; 1985 Jun; 145(6):1053-6. PubMed ID: 4004430
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Home treatment with parenteral antibiotics--a treatment alternative for Scandinavian patients?].
    Bakken JS
    Nord Med; 1990; 105(12):328-30. PubMed ID: 2270197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A retrospective analysis of twice-daily cefotaxime compared to conventional therapy for the treatment of infections in a USA hospital.
    Burke JP; Pestotnik SL; Classen DC; Lloyd JF
    Diagn Microbiol Infect Dis; 1995; 22(1-2):167-9. PubMed ID: 7587034
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of intravenous cefotaxime for treating pneumonia in outpatients.
    Morales JO; Snead H
    Am J Med; 1994 Aug; 97(2A):28-33. PubMed ID: 8059798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outpatient antibiotic therapy for elderly patients. HIAT Study Group.
    Angel JV
    Am J Med; 1994 Aug; 97(2A):43-9. PubMed ID: 8059801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibiotic management and early discharge from hospital: an economic analysis.
    Gray A; Dryden M; Charos A
    J Antimicrob Chemother; 2012 Sep; 67(9):2297-302. PubMed ID: 22623630
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Home management of intravenous antibiotic therapy.
    Poretz DM
    Bull N Y Acad Med; 1988; 64(6):570-6. PubMed ID: 3069167
    [No Abstract]   [Full Text] [Related]  

  • 53. Drug utilization evaluation of third generation cephalosporins using core drug use indicators.
    Kaliamoorthy K; Sankaralingam R; Punniyakotti S; Janardhan V; Cheekala UR
    Pak J Pharm Sci; 2012 Apr; 25(2):339-42. PubMed ID: 22459458
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inpatient versus outpatient parenteral antibiotic therapy at home for acute infections in children: a systematic review.
    Bryant PA; Katz NT
    Lancet Infect Dis; 2018 Feb; 18(2):e45-e54. PubMed ID: 28822781
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost savings and economic considerations using home intravenous antibiotic therapy for cystic fibrosis patients.
    Kane RE; Jennison K; Wood C; Black PG; Herbst JJ
    Pediatr Pulmonol; 1988; 4(2):84-9. PubMed ID: 3132695
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Home infusion therapy: comparison of costs for intravenous immunoglobulin.
    Bielory L; Long GC
    N J Med; 1993 Jul; 90(7):512-5. PubMed ID: 8355890
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-effectiveness of outpatient parenteral antibiotics: a review of the literature.
    Balinsky W; Nesbitt S
    Am J Med; 1989 Sep; 87(3):301-5. PubMed ID: 2505615
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cefotaxime in the treatment of severe infections.
    Habte-Gabr E; Zergabachew A
    East Afr Med J; 1985 Oct; 62(10):744-51. PubMed ID: 4092631
    [No Abstract]   [Full Text] [Related]  

  • 59. Residential addiction treatment for injection drug users requiring intravenous antibiotics: a cost-reduction strategy.
    Jewell C; Weaver M; Sgroi C; Anderson K; Sayeed Z
    J Addict Med; 2013; 7(4):271-6. PubMed ID: 23648642
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outpatient parenteral antibiotic therapy. Management of serious infections. Part I: Medical, socioeconomic, and legal issues. Costs and benefits.
    Milkovich G
    Hosp Pract (Off Ed); 1993 Jun; 28 Suppl 1():39-43. PubMed ID: 8505397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.